Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock
Status:
RECRUITING
Trial end date:
2026-05-15
Target enrollment:
Participant gender:
Summary
The aim of the present study is to verify whether the earlier association of vasopressin and norepinephrine, in patients in septic shock, determines variations in terms of use of renal function replacement techniques in the first 7 days of hospitalization in Intensive Care, compared to patients in whom vasopressin is added only when norepinephrine reaches a higher dose.